2020
DOI: 10.2217/nnm-2019-0320
|View full text |Cite
|
Sign up to set email alerts
|

Rifampicin-Loaded Nanotransferosomal Gel for Treatment of Cutaneous Leishmaniasis: Passive Targeting Via Topical Route

Abstract: Aim: In this study, the targeting of rifampicin (RIF)-loaded nanotransfersomes (NTs) incorporated in chitosan gel for leishmania-infected macrophages via the topical route was investigated. Materials & methods: NTs were prepared through a thin-film hydration process and incorporated into chitosan gel. Results: The mean particle size of the NTs was 190 nm, with 83% encapsulation efficiency. The permeation rate of the NTs was threefold higher than that of the RIF solution. The NTs improved cellular internali… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
27
0
2

Year Published

2020
2020
2025
2025

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 56 publications
(29 citation statements)
references
References 70 publications
0
27
0
2
Order By: Relevance
“…Chitosan (CS) plays an important role as a rheological modifier in IBU release and its penetration into the receiver part of the Franz cells. In addition, the bioadhesive characteristics of chitosan improve drug retention at the site of application and prolong the release rate of the incorporated drug [ 44 ]. A similar result was found in the study conducted by Abioye et al [ 18 ] aimed at developing a chitosan–ibuprofen–gellan nanogel, where the chitosan provides controlled release of IBU in the nanogel.…”
Section: Resultsmentioning
confidence: 99%
“…Chitosan (CS) plays an important role as a rheological modifier in IBU release and its penetration into the receiver part of the Franz cells. In addition, the bioadhesive characteristics of chitosan improve drug retention at the site of application and prolong the release rate of the incorporated drug [ 44 ]. A similar result was found in the study conducted by Abioye et al [ 18 ] aimed at developing a chitosan–ibuprofen–gellan nanogel, where the chitosan provides controlled release of IBU in the nanogel.…”
Section: Resultsmentioning
confidence: 99%
“…A sample of the test formulation was diluted suitably and adsorbed on carbon-coated copper grid. The surface adsorbed test formulation was negatively stained with a drop of 1% phosphotungstic acid followed by drying at room temperature [ 36 , 37 ].…”
Section: Methodsmentioning
confidence: 99%
“…A clinical study including patients affected by L. tropica and having received a drug combination rifampicin-omeprazole appeared successful, but this study did not include patients treated with rifampicin alone [ 51 ]. Considering these controversial data obtained by parenteral route, a topical application was prepared consisting of rifampicin (RIF)-loaded nanotransferosomes (NTs) incorporated in a chitosan gel [ 52 ]. The particle size was 190 nm, with an 83% encapsulation efficiency.…”
Section: Chitosan-based Drug Loaded Formulations For the Chemothermentioning
confidence: 99%
“…The particle size was 190 nm, with an 83% encapsulation efficiency. Some advantages have been observed by using this formulation such as a three times higher permeation rate than the RIF solution, an enhanced macrophage uptake, and better in vitro and in vivo antileishmanial activities making this formulation worthy of further studies [ 52 ].…”
Section: Chitosan-based Drug Loaded Formulations For the Chemothermentioning
confidence: 99%